在可切除的NSCLC中新辅助向治疗:当前和未来的前景
Jay M Lee1, Ciaran J McNamee2, Eric Toloza3
1Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
概括
新辅助向疗法对具有特定基因突变的早期非小细胞肺癌 (NSCLC) 具有前景. 需要进一步的研究来将这些治疗方法确立为护理标准,改善超越当前选择的结果.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 胸部外科手术 胸部外科手术
背景情况:
- 早期非小细胞肺癌 (NSCLC) 的标准治疗包括手术和辅助疗法,但转移性复发仍然是一个重大挑战.
- 针对性疗法 (TT) 在晚期NSCLC中表现出成功,促使对其在早期疾病的术后使用进行调查.
- 目前,只有辅助性奥西默蒂尼布被批准,没有标准的新辅助性TT可用于早期NSCLC.
研究的目的:
- 审查新出现的关于早期NSCLC新辅助TT的数据.
- 讨论生物标志物测试对于确定适合新辅助性TT的候选者的重要性.
- 解决新辅助TT作为标准护理的挑战和安全考虑.
主要方法:
- 审查当前文献和正在进行的临床试验新辅助性TT在早期NSCLC.
- 讨论生物标志物测试策略和早期反应标志物.
- 在外科手术前的环境中分析安全概况.
主要成果:
- 最初的数据表明,新辅助性TT在EGFR或ALK阳性早期NSCLC患者中是有效的,并且耐受性良好.
- 对于患者的选择,全面的生物标志物测试至关重要.
- 目前正在进行的试验正在评估各种新辅助性TT的疗效和安全性.
结论:
- 新辅助性TT是一种有前途的方法,可以改善早期NSCLC的结果,特别是对于具有可操作突变的患者.
- 来自正在进行的试验的进一步数据对于确定新辅助TT是否将成为新的护理标准至关重要.
- 解决响应标志物识别和术后安全方面的挑战是临床实施的关键.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


